ANVRX
Price
$10.95
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
551.01M
OAKIX
Price
$33.05
Change
+$0.25 (+0.76%)
Updated
Jun 2 closing price
Net Assets
12.9B
Interact to see
Advertisement

ANVRX vs OAKIX

Header iconANVRX vs OAKIX Comparison
Open Charts ANVRX vs OAKIXBanner chart's image
ANVRX vs OAKIX Comparison Chart in %
View a ticker or compare two or three
VS
ANVRX vs. OAKIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVRX is a Hold and OAKIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OAKIX has more cash in the bank: 12.9B vs. ANVRX (551M). ANVRX pays higher dividends than OAKIX: ANVRX (3.06) vs OAKIX (1.82). ANVRX was incepted earlier than OAKIX: ANVRX (7 years) vs OAKIX (34 years). ANVRX (1.68) is less costly to investors than OAKIX (1.06). ANVRX is a more actively managed with annual turnover of: 71.00 vs. OAKIX (51.00). OAKIX has a lower initial minimum investment than ANVRX: OAKIX (0) vs ANVRX (2500). ANVRX annual gain was more profitable for investors over the last year : 16.33 vs. OAKIX (14.26). OAKIX (14.80) and ANVRX (14.75) have equivalent 5 years return.
ANVRXOAKIXANVRX / OAKIX
Total Expense Ratio1.681.06158%
Annual Report Gross Expense Ratio1.681.06158%
Fund Existence7 years34 years-
Gain YTD7.1431.692422%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets551M12.9B4%
Annual Yield % from dividends3.061.82168%
Returns for 1 year16.3314.26115%
Returns for 3 years22.0933.5666%
Returns for 5 years14.7514.80100%
Returns for 10 yearsN/A77.55-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMP86.090.94
+1.10%
Tompkins Financial Corp
ITUB7.860.07
+0.94%
Itau Unibanco Banco Holding SA
QS9.200.06
+0.66%
QuantumScape Corp
ASPC11.05-0.01
-0.05%
A Spac III Acquisition Corp
CNTX2.42-0.37
-13.26%
Context Therapeutics